N4 Pharma Plc (LON:N4P – Get Free Report) dropped 15.4% during trading on Friday . The stock traded as low as GBX 0.50 ($0.01) and last traded at GBX 0.55 ($0.01). Approximately 5,556,544 shares changed hands during trading, an increase of 363% from the average daily volume of 1,199,078 shares. The stock had previously closed at GBX 0.65 ($0.01).
N4 Pharma Price Performance
The business’s 50-day simple moving average is GBX 0.64 and its two-hundred day simple moving average is GBX 0.57. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62. The stock has a market cap of £2.17 million, a P/E ratio of -55.00 and a beta of -0.37.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than N4 Pharma
- Where Do I Find 52-Week Highs and Lows?
- Fast-Growing Companies That Are Still Undervalued
- What is Forex and How Does it Work?
- Top Cybersecurity Stock Picks for 2025
- What is a Low P/E Ratio and What Does it Tell Investors?
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
